000 | 01897 a2200493 4500 | ||
---|---|---|---|
005 | 20250517223124.0 | ||
264 | 0 | _c20191031 | |
008 | 201910s 0 0 eng d | ||
022 | _a1582-4934 | ||
024 | 7 |
_a10.1111/jcmm.13701 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVageli, Dimitra P | |
245 | 0 | 0 |
_aCurcumin prevents the bile reflux-induced NF-κB-related mRNA oncogenic phenotype, in human hypopharyngeal cells. _h[electronic resource] |
260 |
_bJournal of cellular and molecular medicine _c09 2018 |
||
300 |
_a4209-4220 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnticarcinogenic Agents _xpharmacology |
650 | 0 | 4 |
_aBile _xchemistry |
650 | 0 | 4 |
_aBile Acids and Salts _xantagonists & inhibitors |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 |
_aEpithelial Cells _xcytology |
650 | 0 | 4 |
_aErbB Receptors _xgenetics |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 |
_aHypopharynx _xcytology |
650 | 0 | 4 |
_aInterleukin-6 _xgenetics |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPrimary Cell Culture |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-rel _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
650 | 0 | 4 |
_aSTAT3 Transcription Factor _xgenetics |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aTranscription Factor RelA _xgenetics |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xgenetics |
650 | 0 | 4 |
_aWnt-5a Protein _xgenetics |
700 | 1 | _aDoukas, Sotirios G | |
700 | 1 | _aSpock, Todd | |
700 | 1 | _aSasaki, Clarence T | |
773 | 0 |
_tJournal of cellular and molecular medicine _gvol. 22 _gno. 9 _gp. 4209-4220 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcmm.13701 _zAvailable from publisher's website |
999 |
_c28538923 _d28538923 |